Lung Allocation Score Exceptions in Persons with Cystic Fibrosis Undergoing Lung Transplant
Year: 2023
Type: article
Study design: Observational Study
Abstract: Rationale Lung transplantation can extend the lives of individuals with advanced cystic fibrosis (CF). Until March 2023, the Lung Allocation Score (LAS) was used in the United States to determine transplant priority. Certain clinical events or attributes (“risk events”) that are not included in the LAS (e.g., massive hemoptysis) are relatively common and prognostically important in CF and may prompt an exception request to increase priority for donor lungs. The new Lung Composite Allocation Score (CAS) also allows for exceptions based on the same principles. Objectives To evaluate the frequency of LAS exceptions in persons with CF (PwCFs) listed for lung transplantation and assess whether LAS exceptions are associated with improved waitlist outcomes for PwCFs compared with similarly “at-risk” individuals without LAS exceptions. Methods A merged dataset combining data from the CF Foundation Patient Registry and the Organ Procurement and Transplantation Network (2005–2019) was used to identify PwCFs listed for lung transplantation. We compared waitlist outcomes between PwCFs with a LAS exception versus those without an exception despite having a risk event. Risk events were defined as an episode of massive hemoptysis, pneumothorax, at least three moderate/severe pulmonary exacerbations, and/or a decrease in forced expiratory volume in 1 second by ⩾30% predicted (absolute) in the prior 12 months. Analyses were performed using competing risk regression with time to transplantation as the primary outcome and death without a transplant as a competing risk. Results Of 3,538 listings from 3,309 candidates, 2% of listings (n = 81) had at least one exception. Candidates with an exception and those with a risk event but no exception received lung transplants more slowly than people without an exception or risk event (subdistribution hazard ratio [95% confidence interval]: LAS exception cohort, 0.66 [0.52–0.85]; risk event cohort without exceptions, 0.79 [0.72–0.86]). There was no difference between those with LAS exceptions and those at risk without LAS exceptions: subdistribution hazard ratio, 0.84 (0.66–1.08). Conclusions LAS exceptions are rare in PwCFs listed for lung transplantation. LAS exceptions resulted in a similar time to transplantation for PwCFs compared with similarly at-risk individuals. As we enter the CAS era, these LAS-based results are pertinent to improve risk stratification among PwCFs being considered for lung transplantation.
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1798473549, G1840787502, G3422012727, Institute of Translational Health Sciences, G3801776485, G3991547501, Predicting survival and planning for lung transplantation in severe cystic fibrosis, G4520310076, The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome, G7099174892, G7192914850, G7489766174, G8522891902, G870600734, G8722647953, G9000268964, Pulmonary and Critical Care Medicine Research Training Grant, Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era
OpenAlex ID: W4387948680
